Here's What Key Metrics Tell Us About Amicus Therapeutics (FOLD) Q3 Earnings

For the quarter ended September 2024, Amicus Therapeutics (FOLD) reported revenue of $141.52 million, up 36.7% over the same period last year. EPS came in at$ 0.10, compared to - $0.07 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of$ 133.91 million, representing a surprise of +5.68%. The company delivered an EPS surprise of +25.00%, with the consensus EPS estimate being $0.08.While investors scrutinize revenue and earnings changes year-over-year and how they compare w ...